21. 217. Antimicrobial Activity of Dalbavancin against Gram-Positive Bacteria Isolated from Patients Hospitalized with Bacteremia in United States and European Medical Centers: Results from the International Dalbavancin Evaluation of Activity (IDEA) Program (2018-202). (4th December 2021) Authors: Sader, Helio S; Castanheira, Mariana; Castanheira, Mariana; Huband, Michael D; Shortridge, Dee; Carvalhaes, Cecilia G; Mendes, Rodrigo E Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S216 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
22. 2176. In Vitro Evaluation of Delafloxacin Activity Against Contemporary US Isolates from Cystic Fibrosis Patients Hospitalized with Pneumonia: Results from the SENTRY Antimicrobial Surveillance Program (2019-2021). (15th December 2022) Authors: Shortridge, Dee; Streit, Jennifer M; Huband, Michael D; Castanheira, Mariana Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
23. 2373. Evaluation of Delafloxacin Activity and Treatment Outcome for Phase 3 Acute Bacterial Skin and Skin Structure Infection Clinical Trial Anaerobic Isolates. (26th November 2018) Authors: Shortridge, Dee; McCurdy, Sandra P; Rhomberg, Paul R; Huband, Michael D; Flamm, Robert K Journal: Open forum infectious diseases Issue: Volume 5(2018)Supplement 1 Page Start: S706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
24. 430. Oritavancin Activity Against Gram-positive Pathogens Causing Bloodstream Infections in Hematology/Oncology and Transplant Units in US Medical Centers (2010-2019). (15th December 2022) Authors: Carvalhaes, Cecilia G; Shortridge, Dee; Sader, Helio S; Mendes, Rodrigo E Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
25. 642. In Vitro Activity of Cefiderocol and Comparator Agents Against Molecularly Characterized Enterobacterales Clinical Isolates Causing Infection in United States Hospitals (2020-2021). (15th December 2022) Authors: Mendes, Rodrigo E; Kimbrough, John H; Kantro, Valerie; Shortridge, Dee; Sader, Helio S; Streit, Jennifer M; Castanheira, Mariana Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
26. 643. Cefiderocol In vitro Activity Against Molecularly Characterized Pseudomonas aeruginosa and Acinetobacter baumannii-calcoaceticus complex Clinical Isolates Causing Infection in United States Hospitals (2020-2021). (15th December 2022) Authors: Mendes, Rodrigo E; Hubler, Cory; Kantro, Valerie; Shortridge, Dee; Sader, Helio S; Streit, Jennifer M; Castanheira, Mariana Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
27. 644. Activity of Meropenem-Vaborbactam and Comparators Against Isolates from Patients in Hematology/Oncology and Transplant Units in the United States. (15th December 2022) Authors: Shortridge, Dee; Deshpande, Lalitagauri M; Carvalhaes, Cecilia G; Castanheira, Mariana Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
28. 645. Trends in the Susceptibility of US Acinetobacter baumannii-calcoaceticus Species Complex and Stenotrophomonas maltophilia Isolates to Minocycline, 2014-2021. (15th December 2022) Authors: Shortridge, Dee; Carvalhaes, Cecilia G; Streit, Jennifer M; Castanheira, Mariana Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
29. 660. In vitro activity of cefiderocol against difficult-to-treat resistance European Gram-negative bacterial pathogens from the multi-national sentinel surveillance study, SENTRY in 2020 and 2021. (15th December 2022) Authors: Santerre Henriksen, Anne Laurence; Longshaw, Christopher M; Shortridge, Dee; Streit, Jennifer M; Takemura, Miki; Yamano, Yoshinori Journal: Open forum infectious diseases Issue: Volume 9:(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
30. Activity of Ceftolozane-Tazobactam Against Gram-Negative Isolates from Australia and New Zealand as part of the PACTS Surveillance 2016-2018. (December 2022) Authors: Shortridge, Dee; Streit, Jennifer; Pfaller, Michael; Tulloch, Merrin; Chen, Wei-Ting; Castanheira, Mariana Journal: Journal of global antimicrobial resistance Issue: Volume 31(2022) Page Start: 98 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗